期刊文献+

SphK1和FAK对人结肠癌HCT116细胞上皮间质转化的影响 被引量:14

Effects of Sph K1 and FAK on epithelial-mesenchymal transition in colon cancer HCT116 cells
下载PDF
导出
摘要 目的:研究鞘氨醇激酶1(sphingosine kinase l,Sph K1)和黏着斑激酶(focal adhesion kinase,FAK)对人结肠癌HCT116细胞上皮间质转化(epithelial-mesenchymal transition,EMT)的影响。方法:将人结肠癌HCT116细胞分成3组:采用Sph K1抑制剂N,N-二甲基鞘胺醇(N,N-dimethylsphingosine,DMS)、FAK抑制剂PF573228和相同体积的培养基分别处理细胞。MTT法检测细胞活力,Western blot方法检测Sph K1、FAK、E-cadherin、N-cadherin、vimentin和基质金属蛋白酶2(MMP2)蛋白的表达,real-time PCR检测Sph K1、鞘氨醇1-磷酸(S1P)、FAK、E-cadherin和vimentin mRNA的表达,并应用细胞划痕实验检测肿瘤细胞的迁移能力。结果:PF573228和DMS均明显抑制人结肠癌HCT116细胞的活力,并呈时间剂量依赖性。DMS抑制Sph K1的表达,同时下调FAK、N-cadherin、vimentin和MMP2蛋白的表达,而上调E-cadherin蛋白表达上调。PF573228明显抑制FAK的表达,同时抑制Sph K1、N-cadherin、vimentin和MMP2的表达,上调E-cadherin蛋白的表达(P<0.01)。划痕实验显示PF573228和DMS显著抑制HCT116细胞的迁移能力(P<0.01)。与对照组比较,PF573228组和DMS组FAK、Sph K1、S1P以及vimentin mRNA的表达明显下调,而E-cadherin mRNA的表达则明显上调(P<0.05)。结论:Sph K1和FAK信号通路可能在结肠癌HTC116细胞上皮间质转化过程中发挥重要作用。 AIM:To investigate the effects of sphingosine kinase l( Sph K1) and focal adhesion kinase( FAK)on the epithelial-mesenchymal transition( EMT) of human colon cancer HCT116 cells.METHODS:Human colon cancer HCT116 cells were divided into 3 groups.N,N-dimethylsphingosine( DMS) was used to suppress the activity of Sph K1.PF573228 was used to suppress the activation of FAK.The cells treated with equal volume of culture medium severed as control group.The cell viability was measured by MTT assay.The protein expression of Sph K1,FAK and the EMT relative protein E-cadherin,N-cadherin,vimentin and matrix metalloproteinase( MMP) 2 was analyzed by Western blot.The mRNA expression of Sph K1,sphingosine-1-phosphate( S1P),FAK,E-cadherin and vimentin was detected by real-time PCR.The ability of tumor cell migration was measured by wound-healing assay.RESULTS:The cell viability of HCT116 cells was suppressed by DMS and PF573228 in dose and time dependent manners.DMS significantly suppressed the expression of Sph K1,FAK,N-cadherin,vimentin and MMP2,meanwhile enhanced the expression of E-cadherin.PF573228 reduced the expression of FAK,Sph K1,N-cadherin,vimentin and MMP2,meanwhile increased the expression of E-cadherin( P〈0.01).In addition,the migration ability of HCT116 cells was significantly decreased by treating with DMS and PF573228( P〈0.01).Compared with control group,the mRNA expression of FAK,Sph K1,S1 P and vimentin was decreased,while the expression of E-cadherin was increased significantly in PF573228 group and DMS group( P〈0.05).CONCLUSION:Sph K1 and FAK signaling pathways may play an important role in the occurrence of EMT in the colon cancer HCT116 cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2016年第3期439-444,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.81460380) 广西自然科学基金资助项目(No.2011GXNSFA018182) 广西卫生厅基金资助项目(No.GZKZ10-107)
关键词 鞘氨醇激酶1 黏着斑激酶 上皮间质转化 人结肠癌细胞 Sphingosine kinase 1 Focal adhesion kinase Epithelial-mesenchymal transition Human colon cancer cells
  • 相关文献

参考文献5

二级参考文献44

  • 1隋春阳,李航宇,胡勇,宗志红,李洪秀,郭仁宣.HSP70-肿瘤肽复合物的纯化及其对肝癌细胞株HepG-2增殖的作用[J].世界华人消化杂志,2006,14(18):1775-1779. 被引量:5
  • 2Morrison CD, Parvani JG, Sehiemann WP. The relevance of the TGF-β paradox to EMT-MET programs [ J ]. Cancer Lett, 2013, Mar 5. [ Epub ahead of print].
  • 3Hader C, Marlier A, Cantley L. Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2 [J]. Oncogene , 2010, 29(7) : 1031-1040.
  • 4Wang Y, Lui WY. Transforming growth factor-β1 attenu- ates junctional adhesion molecule-A and contributes to breast cancer cell invasion [ J]. Eur J Cancer, 2012,48 (18) :3475-3487.
  • 5Mani SA, Yang J, Brooks M, et al. Mesenchyme Fork- head 1 (FOXC2) plays a key role in metastasis and is as- sociated with aggressive basal-like breast cancers [ J ]. PNAS, 2007, 104(24): 10069-10074.
  • 6Zagouri F, Bago-Horvath Z, Rossler F, et al. High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer[ J]. Br J Cancer, 2013,108 (5) :1100-1105.
  • 7Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mes- enehymal composition [ J ]. Science, 2013, 339 ( 6119 ) : 580-584.
  • 8Yao D, Dai C, Peng S. Mechanism of the mesenchymal- epithelial transition and its relationship with metastatic tumor formation [ J ]. Mol Cancer Res, 2011, 9 ( 12 ) : 1608-1620.
  • 9Ono Y, Hayashida T, Konagai A, et al. Direct inhibition of the transforming growth factor-13 pathway by protein- bound polysaccharide through inactivation of Smad2 signa- ling[ J]. Cancer Sci, 2013,32(12) : 1549-1559.
  • 10Freudlsperger C, Bian Y, Contag Wise S, et al. TGF-t3 and NF-KB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers [ J ]. Oncogene, 2013,32 (12) : 1549-1559.

共引文献113

同被引文献78

  • 1Li-Ran Fu,Sheng-Wei Guo,Xian-Hui Liu.Effect of Yiqi Jianpi plus anticancer herbs on spleen deficiency in colorectal cancer and its anti-tumor role[J].Asian Pacific Journal of Tropical Medicine,2014,7(5):378-381. 被引量:4
  • 2张小博,李艳会,李开良,张平.VEGF、MMP-2、MMP-9在胰腺癌中的表达及临床意义[J].中国老年学杂志,2014,34(2):327-329. 被引量:16
  • 3TORRE LA, BRAY F, SIEGEL RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2) :87-108.
  • 4CHEN W, ZHENG R, BAADE PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016,66(2): 115-132.
  • 5SPIEGEL S, MILSTIEN S. The outs and the ins of sphingosine- 1-phosphate in immunity[J]. Nat Rev Immunol, 2011,11 (6): 403-415.
  • 6PROIA RL, HLA T. Emerging biology of sphingosine-1- phosphate: its role in pathogenesis and therapy [J]. J Clin Invest, 2015,125(4) : 1379-1387.
  • 7HERNANDEZ-CORBACHO MJ, CANALS D, ADADA MM, et al. Tumor necrosis factor-alpha (TNFalpha)-induced ceramide generation via ceramide synthases regulates loss of focal adhesion kinase (FAK) and programmed cell death [J]. J Biol Chem, 2015,290(42) : 25356-25373.
  • 8DEL SV, LIZARDO DY, LI N, et al. Differential regulation of specific sphingolipids in colon cancer cells during staurosporine- induced apoptosis [J]. Chem Biol, 2015,22(12) : 1662-1670.
  • 9YESTER JW, TIZAZU E, HARIKUMAR KB, et al. Extracellular and intracellular sphingosine-1-phosphate in cancer[J]. Cancer Metastasis Rev, 2011,30(3-4) :577-597.
  • 10FURUYA H, SHIMIZU Y, KAWAMORI T. Sphingolipids in cancer [ J ]. Cancer Metastasis Rev, 2011,30 (3-4) : 567-576.

引证文献14

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部